Cellogen Therapeutics

We are excited to announce that @cellogenindia Cellogen Therapeutics has secured strategic investment from the Kotak Life Sciences Fund, managed by Kotak Alternate Asset Managers. This partnership marks an important milestone in our journey to build accessible, scalable, and indigenous cell & gene therapies from India for the world. The funding will help accelerate our CAR-T clinical programs, expand our gene therapy pipeline, and strengthen our GMP manufacturing and regulatory capabilities. We thank our partners, team, collaborators, and supporters for believing in our vision to make advanced therapies accessible to more patients. #CellogenTherapeutics #KotakLifeSciencesFund #StrategicInvestment #HealthcareInnovation #Biotechnology #CellTherapy #GeneTherapy #CARTTherapy #LifeSciences #BiotechIndia vccircle.com/kotakaltslife-…

Introducing NuCleave™️, a high-purity, high-efficiency recombinant endonuclease, precision engineered for the demands of modern cell and gene therapy manufacturing and R&D. No more junk genomic DNA to hinder your cell and gene therapy results, NuCleave delivers superior nucleic acid clearance with enhanced specific activity. The product comes with a ready to use formulation bypassing the need for complex reconstitutions and dilutions. The activity of enzyme is tried and tested at alkaline conditions aligning with specific needs for viral vector development. Indigenously developed by our expert team, highest quality will now be delivered at the most accessible cost, empowering Indian and global manufacturers to scale with confidence. Beyond the CGT space, NuCleave will be a highly assisting tool for enhancing your results in many methodologies like protein purification, cell lysis during recombinant protein expression, plasmid preparation cleanup, preparation of cell free extracts, mass spectrometry sample preparation, biofilm extracellular DNA cleanup, organelle isolation etc. @CellogenTher #NuCleave #CellAndGeneTherapy #CGT #Biotechnology #Bioprocessing #GeneTherapy #CellTherapy #ViralVector #Biomanufacturing #RecombinantProtein #ProteinPurification

Our AI Scientist, Shivanshu Mishra, explores how AI is transforming complex biological data into real-world healthcare impact—driving smarter decisions and shaping the future of personalized medicine. Read the full blog on our website. #ArtificialIntelligence #HealthcareAI #PersonalizedMedicine #DataScience #BiotechInnovation #HealthTech #AIinHealthcare #FutureOfMedicine cellogentherapeutics.com/blog_detail.ph…

@cellogenindia wishes everyone good health and happiness!! #WorldHealthDay #CellogenTherapeutics #HealthAndHappiness #StayHealthy #WellnessForAll #HealthyLife #HealthMatters #CareForLife #HealthcareInnovation #teamcellogen

Developed by Cellogen Therapeutics, CelAbGen is India’s first AI-driven antibody generation pipeline, redefining how antibodies are designed. Traditional antibody discovery can take over a year of complex lab processes. With CelAbGen, this is now reduced to just 24 hours. By combining deep learning, diffusion models, and structural biology, CelAbGen designs de novo, epitope-specific antibodies — human-like, stable, and optimised for precise target binding. From backbone generation to CDR loop optimisation, every stage is accelerated and guided by AI, delivering novel, high-affinity antibodies ready for validation. This breakthrough transforms months of uncertainty into hours of intelligent design. #ArtificialIntelligence #Biotech #AIinHealthcare #Innovation #DeepLearning #Biotechnology #HealthTech #FutureOfHealthcare #StartupIndia #MakeInIndia #LifeSciences #AIInnovation

Team Cellogen wishes you Eid Mubarak!! #EidMubarak #TeamCellogen #EidWishes

@cellogenindia is Hiring! We are looking for passionate and skilled professionals to join our growing team. If you’re ready to work at the forefront of innovation in Cell & Gene Therapy. Open Positions: 1. Regulatory Affairs Qualification: Bachelor’s/Master’s in Pharmacy, Life Sciences, Biotechnology, Microbiology, or related field from a recognized university. Experience: Minimum 1 year of relevant experience in Regulatory Affairs (Pharma/Biotech/CRO/Clinical Research) Requirements: • Understanding of pharmaceutical and clinical research regulatory frameworks • Familiarity with GCP, GLP, GMP and applicable regulatory guidelines • Experience in preparation and review of regulatory dossiers, submissions, and supporting documentation • Knowledge of quality documentation systems, SOP management, and regulatory record keeping • Ability to ensure regulatory compliance and maintain proper documentation as per quality standards 2. Executive Assistant (Administration & Operations) Qualification: Graduate/Postgraduate in any discipline from a recognized university. Requirements: • Proficiency in MS Office & MIS reporting • Experience in administration & office coordination • Strong interpersonal and written communication skills in (English & Hindi) • Ability to manage official documentation & records Apply here: lnkd.in/gRQqDZij Or send your resume to: contact@cellogentherapeutics.com Join us and be a part of something impactful! #Hiring #CellogenTherapeutics #BiotechJobs #RegulatoryAffairs #ExecutiveAssistant #LifeSciences #CareerGrowth #JobOpening

Stay updated with the latest breakthroughs in Cell & Gene Therapy! Subscribe to Cellogen Therapeutics’ Monthly Newsletter and get insights on cutting-edge research, innovations, and developments from India and across the globe. From AI-driven discoveries to advancements in therapeutic innovation, our newsletter keeps you informed about the future of medicine. Click the link to read our latest news and subscribe to our newsletter: cellogentherapeutics.com/newsletters.php #CellogenTherapeutics #CellAndGeneTherapy #BiotechInnovation #HealthcareInnovation #BiotechNews #GeneTherapy #MedicalResearch #BiotechIndia

CasAInova: World’s First AI-Engineered CRISPR Cas12 Breakthrough! CasAInova—a pioneering AI platform that designs compact, ultra-precise Cas12 and Cas9 variants from scratch. The platform is powered by deep learning trained on 1M+ sequences. CasAInova delivers smaller, high-fidelity enzymes with unmatched efficiency, enhanced PAM flexibility, and zero off-target risk. Ideal for AAV and LNP delivery, it is set to redefine safe, precise gene editing and usher in a new era of transformative therapeutics. #CasAInova #CRISPR #GenomeEditing #AIinBiotech #ArtificialIntelligence #GeneEditing #Cas12 #Biotechnology #SyntheticBiology #PrecisionMedicine #BiotechInnovation #LifeSciences #teamcellogen

At @cellogenindia, these inspiring young women represent the next generation of innovators in science and biotechnology. With curiosity, dedication, and determination, they are stepping into laboratories today to build the medical breakthroughs of tomorrow. On this International Women’s Day, we celebrate the power of women in science — the thinkers, researchers, and innovators who are transforming healthcare and giving hope to countless lives. . . . #InternationalWomensDay #WomensDay2026 #WomenInScience #WomenInBiotech #FutureScientists #WomenResearchers #ScienceInnovation #WomenInHealthcare #Cellogen #EmpoweringWomen #InspiringWomen #NextGenScientists

The central shift is conceptual: genome editors are no longer discovered — they are designed. In his latest blog, our Junior Scientist, Kashif Husain, explores how AI is transforming the future of genome editing. #GenomeEditing #CRISPR #ArtificialIntelligence #AIinBiotech #ComputationalBiology #Biotechnology #GeneEditing #BiotechInnovation #LifeSciences Read the full blog- cellogentherapeutics.com/blog_detail.ph…

Holi is a celebration of new beginnings, brighter days, and the power of positivity. At Cellogen Therapeutics, we believe the most powerful colour is hope — the hope that innovative science brings to patients and families seeking better treatment options. As colours fill the air, we remain committed to advancing therapies that transform lives and build healthier tomorrows. May this festival inspire renewed strength, resilience, and breakthroughs that truly make a difference. Wishing you a vibrant and meaningful Holi. #HappyHoli #Holi2026 #FestivalOfColors #InnovationWithPurpose #ScienceWithHope #CellAndGeneTherapy #Biotechnology #TransformingLives #FutureOfMedicine #teamcellogen

LVDO, our Lentivirus Concentrator, an innovative solution designed to concentrate lentiviral vector. Lentiviral vectors (LVVs) are most powerful tools widely used for stable gene delivery in CAR-T cell therapy, gene editing, and cell line development due to their ability to integrate into the host genome and ensure long-term expression. We’ve integrated an AI-based Chatbot Assistant into LVDO— helping users with titer calculations, reagent ratios, troubleshooting tips, and protocol clarifications. The chatbot is continuously updated with application data and user feedback, ensuring accurate and reliable guidance for both new and experienced users. Every batch of LVDO undergoes rigorous QC validation for reproducibility and viral recovery efficiency, ensuring consistent performance across users and scales. #LVDO #LentiviralVector #Lentivirus #GeneTherapy #CARTCellTherapy #GeneEditing #CellLineDevelopment #Biotechnology #LifeSciences #CellTherapy #ViralVectors #LabInnovation #ResearchTools #teamcellogen

Join the Team Building India’s Largest Viral Vector Manufacturing Facility (500L+) @cellogenindia is expanding! We are hiring Manufacturing Associates to join our Cell & Gene Therapy – Lentiviral Vector Manufacturing Team. Be part of a pioneering mission to scale advanced viral vector manufacturing in India. Open Position: Manufacturing Associates (Freshers and early-career professionals are encouraged to apply.) Eligibility Criteria: • B.Tech / M.Sc / M.Tech in Biotechnology or related Life Sciences discipline • Knowledge of mammalian cell culture • Understanding of molecular biology techniques (PCR, qPCR, etc.) • Familiarity with protein purification processes • Prior experience in GMP/GLP facilities is an added advantage Key Responsibilities: • Execute upstream and downstream processing • Support scale-up operations from 50L to 500L+ lentiviral vector manufacturing • Maintain compliance with GMP protocols and quality standards Interested candidates may also submit their application by completing the Form: docs.google.com/forms/d/e/1FAI… Send your resume to: info@cellogentherapeutics.com Visit: cellogentherapeutics.com #CellogenTherapeutics #HiringNow #BiotechnologyJobs #CellAndGeneTherapy #LentiviralVectors #ViralVectorManufacturing #BiotechCareers #LifeSciencesJobs #ManufacturingAssociate #GMPManufacturing #BiotechIndia #ResearchAndInnovation #Biopharma #CareersInScience #teamcellogen

“ViroVbots,” an innovation in lentivirals, holds the potential to transform the treatment of complex diseases affecting the brain, eye, and stem cells. Sharing expert insights, our Junior scientist Shaikh Nisar Rahim, explores this breakthrough in his latest blog. Read now and discover the science shaping tomorrow. #Innovation #LentiviralResearch #Biotech #HealthcareInnovation cellogentherapeutics.com/blog_detail.ph…

The persistence of CAR T cells and antigen escape remain major barriers to durable therapeutic success in hematologic malignancies. Read our study in @NatureComms on how we overcome these challenges. #CARTCellTherapy #Immunotherapy #CancerResearch #BiotechResearch Take a look at my article! nature.com/articles/s4146…

Read our Research Associate, Juli Gupta’s blog on how structure-driven nanobody design is shaping cancer treatment. #CancerResearch #NanobodyDesign #Biotechnology #BiotechInnovation #CancerTherapy cellogentherapeutics.com/blog_detail.ph…

Cellogen Therapeutics proudly congratulates Siddhi Datri and Tigmanshu Shah Bhari on being selected for the Cellogen Innovators Research Fellowship (CIRF) 2025–26. #CellogenTherapeutics #CIRF2025 #ResearchFellowship #FutureInnovators #ScientificExcellence #BiotechResearch #InnovationInScience #NextGenResearchers